BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/13/2021 9:21:26 AM | Browse: 486 | Download: 641
 |
Received |
|
2021-01-30 16:04 |
|
Peer-Review Started |
|
2021-01-30 16:07 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-05-05 19:03 |
|
Revised |
|
2021-05-10 23:43 |
|
Second Decision |
|
2021-06-16 07:40 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-06-16 11:31 |
|
Articles in Press |
|
2021-06-16 11:31 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-07-08 22:40 |
|
Publish the Manuscript Online |
|
2021-07-13 09:21 |
| ISSN |
2220-3230 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Transplantation |
| Manuscript Type |
Meta-Analysis |
| Article Title |
Rituximab or plasmapheresis for prevention of recurrent focal segmental glomerulosclerosis after kidney transplantation: A systematic review and meta-analysis
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Boonphiphop Boonpheng, Panupong Hansrivijit, Charat Thongprayoon, Shennen A Mao, Pradeep K Vaitla, Tarun Bathini, Avishek Choudhury, Wisit Kaewput, Michael A Mao and Wisit Cheungpasitporn |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Wisit Cheungpasitporn, FACP, FASN, FAST, MD, Associate Professor, Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, United States. wcheungpasitporn@gmail.com |
| Key Words |
Focal segmental glomerulosclerosis; Kidney transplantation; Meta-analysis; Plasmapheresis; Transplantation; Systematic review |
| Core Tip |
Focal segmental glomerulosclerosis (FSGS) is associated with a high risk of recurrence after kidney transplantation. Plasmapheresis and/or rituximab has been used to prevent recurrence with conflicting results. This meta-analysis is among the first to report that the use of preemptive rituximab, either alone or in combination with plasmapheresis, or plasmapheresis alone, did not alter the recurrence risk of FSGS after kidney transplantation. |
| Publish Date |
2021-07-13 09:21 |
| Citation |
Boonpheng B, Hansrivijit P, Thongprayoon C, Mao SA, Vaitla PK, Bathini T, Choudhury A, Kaewput W, Mao MA, Cheungpasitporn W. Rituximab or plasmapheresis for prevention of recurrent focal segmental glomerulosclerosis after kidney transplantation: A systematic review and meta-analysis. World J Transplant 2021; 11(7): 303-319 |
| URL |
https://www.wjgnet.com/2220-3230/full/v11/i7/303.htm |
| DOI |
https://dx.doi.org/10.5500/wjt.v11.i7.303 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
